Hepatology(Liver, Pancreatic, Gall Bladder) - Drug Trials For Money

Bile Composition in Healthy and Gallstones Patients

Conditions: Cholelithiasis; Gall Stone; Gall Bladder Disease
Interventions: Diagnostic Test: Bile test; Diagnostic Test: Blood test; Diagnostic Test: Gall stone study; Diagnostic Test: Microbiological bile test
Sponsor: Hospital Son Espases
Not yet recruiting
ClinicalTrials.gov: Gall Bladder | Recruiting, Not yet recruiting, Available Studies | First posted in the last 100 days

June 10, 2019ClinicalTrials.govComments OffHepatology(Liver, Pancreatic, Gall Bladder)Bile | Composition | Gallstones | Healthy | Patients

Conditions: Borderline Resectable Pancreatic Adenocarcinoma; Resectable Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Fluorouracil; Drug: Irinotecan; Drug: Irinotecan Hydrochloride; Drug: Leucovorin; Drug: Leucovorin Calcium; Biological: Nivolumab; Drug: Oxaliplatin; Procedure: Therapeutic Conventional Surgery
Sponsors: Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI)
Not yet recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Conditions: Healthy; Healthy Volunteers
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Conditions: Pancreatic Ductal Adenocarcinoma (PDAC); Cancer of Pancreas; Pancreatic Cancer, Adult; Pancreas Adenocarcinoma; Pancreatic Neoplasms; Pancreatic Cancer Non-resectable; Pancreatic Cancer Resectable
Interventions: Drug: Oxaliplatin; Drug: Leucovorin; Drug: Irinotecan Hydrochloride; Drug: 5-FU
Sponsor: UNC Lineberger Comprehensive Cancer Center
Not yet recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Healthy Participants
Intervention: Drug: Glucagon
Sponsors: Yale University; Merck Sharp & Dohme Corp.
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Conditions: Cirrhosis, Liver; Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Intervention:
Sponsors: Northwestern University; University of California, San Francisco; Scripps Health; University of Wisconsin, Madison; University of Florida; University of Arizona; Stanford University; Columbia University; Weill Medical College of Cornell University; Baylor Scott and White Health; Mayo Clinic
Not yet recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Pancreatic Cancer Non-resectable
Interventions: Drug: Pamrevlumab + Gemcitabine + Nab-paclitaxel; Drug: Placebo + Gemcitabine + Nab-paclitaxel
Sponsor: FibroGen
Recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Conditions: Cancer of the Prostate; Castration-resistant Prostate Cancer
Intervention: Drug: Gadoxetate Sodium
Sponsor: University of Cincinnati
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Conditions: Hepatic Impairment; Healthy Participants
Intervention: Drug: Linzagolix
Sponsor: ObsEva SA
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Telehealth Intervention in Cirrhotics

Conditions: Cirrhosis, Liver; Liver Diseases
Intervention: Behavioral: Intervention
Sponsor: University of Pennsylvania
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 1, 2019ClinicalTrials.govComments OffHepatology(Liver, Pancreatic, Gall Bladder)Cirrhotics | Intervention | Telehealth